These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 12508245

  • 1. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
    Asou H, Gombart AF, Takeuchi S, Tanaka H, Tanioka M, Matsui H, Kimura A, Inaba T, Koeffler HP.
    Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
    [Abstract] [Full Text] [Related]

  • 2. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD.
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [Abstract] [Full Text] [Related]

  • 3. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
    Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG.
    Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
    [Abstract] [Full Text] [Related]

  • 4. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding.
    Cleaves R, Wang QF, Friedman AD.
    Oncogene; 2004 Jan 22; 23(3):716-25. PubMed ID: 14737106
    [Abstract] [Full Text] [Related]

  • 5. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
    Rangatia J, Vangala RK, Singh SM, Peer Zada AA, Elsässer A, Kohlmann A, Haferlach T, Tenen DG, Hiddemann W, Behre G.
    Oncogene; 2003 Jul 24; 22(30):4760-4. PubMed ID: 12879022
    [Abstract] [Full Text] [Related]

  • 6. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG.
    Nat Med; 2001 Apr 24; 7(4):444-51. PubMed ID: 11283671
    [Abstract] [Full Text] [Related]

  • 7. ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha.
    Gombart AF, Grewal J, Koeffler HP.
    J Leukoc Biol; 2007 Jun 24; 81(6):1535-47. PubMed ID: 17347301
    [Abstract] [Full Text] [Related]

  • 8. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction.
    Yang L, Jiang Y, Wu SF, Zhou MY, Wu YL, Chen GQ.
    Carcinogenesis; 2008 Feb 24; 29(2):291-8. PubMed ID: 18024476
    [Abstract] [Full Text] [Related]

  • 9. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
    Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA, Calabretta B.
    Nat Genet; 2002 Jan 24; 30(1):48-58. PubMed ID: 11753385
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBP alpha.
    Fukuchi Y, Shibata F, Ito M, Goto-Koshino Y, Sotomaru Y, Ito M, Kitamura T, Nakajima H.
    EMBO J; 2006 Jul 26; 25(14):3398-410. PubMed ID: 16858416
    [Abstract] [Full Text] [Related]

  • 11. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription.
    Thiel G, Al Sarraj J, Vinson C, Stefano L, Bach K.
    J Neurochem; 2005 Jan 26; 92(2):321-36. PubMed ID: 15663480
    [Abstract] [Full Text] [Related]

  • 12. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
    Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC.
    Cancer Res; 2005 Feb 01; 65(3):861-7. PubMed ID: 15705884
    [Abstract] [Full Text] [Related]

  • 13. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY, Christopeit M, Chen Y, Geletu M, Behre G.
    Exp Hematol; 2008 Nov 01; 36(11):1449-60. PubMed ID: 18687517
    [Abstract] [Full Text] [Related]

  • 14. Essential role of C/EBPalpha in G-CSF-induced transcriptional activation and chromatin modification of myeloid-specific genes.
    Iida S, Watanabe-Fukunaga R, Nagata S, Fukunaga R.
    Genes Cells; 2008 Apr 01; 13(4):313-27. PubMed ID: 18363963
    [Abstract] [Full Text] [Related]

  • 15. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X, Vradii D, Gutierrez S, Lian JB, van Wijnen AJ, Stein JL, Stein GS, Javed A.
    J Cell Biochem; 2005 Nov 01; 96(4):795-809. PubMed ID: 16149049
    [Abstract] [Full Text] [Related]

  • 16. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
    Jost E, do O N, Wilop S, Herman JG, Osieka R, Galm O.
    Leuk Res; 2009 Mar 01; 33(3):443-9. PubMed ID: 18757096
    [Abstract] [Full Text] [Related]

  • 17. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation.
    Foka P, Singh NN, Salter RC, Ramji DP.
    Int J Biochem Cell Biol; 2009 May 01; 41(5):1189-97. PubMed ID: 19027873
    [Abstract] [Full Text] [Related]

  • 18. C/EBPalpha activates the transcription of triacylglycerol hydrolase in 3T3-L1 adipocytes.
    Wei E, Lehner R, Vance DE.
    Biochem J; 2005 Jun 15; 388(Pt 3):959-66. PubMed ID: 15752068
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer.
    Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG.
    Cancer Res; 2002 Jan 15; 62(2):528-34. PubMed ID: 11809705
    [Abstract] [Full Text] [Related]

  • 20. Analysis of leukemogenesis induced by C/EBPα mutations.
    Kato N.
    Rinsho Ketsueki; 2011 Jun 15; 52(6):320-8. PubMed ID: 21737983
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.